BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19505936)

  • 1. Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2R gamma (null) mouse.
    Kato C; Fujii E; Chen YJ; Endaya BB; Matsubara K; Suzuki M; Ohnishi Y; Tamaoki N
    Lab Anim; 2009 Oct; 43(4):402-4. PubMed ID: 19505936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγ
    Yasuda M; Ogura T; Goto T; Yagoto M; Kamai Y; Shimomura C; Hayashimoto N; Kiyokawa Y; Shinohara H; Takahashi R; Kawai K
    Exp Anim; 2017 Oct; 66(4):425-435. PubMed ID: 28679969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
    Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
    Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of human Graafian follicles following transplantation of human ovarian tissue into NOD/SCID/gammac null mice.
    Terada Y; Terunuma-Sato Y; Kakoi-Yoshimoto T; Hasegawa H; Ugajin T; Koyanagi Y; Ito M; Murakami T; Sasano H; Yaegashi N; Okamura K
    Am J Reprod Immunol; 2008 Dec; 60(6):534-40. PubMed ID: 19032615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
    Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
    Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
    Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
    J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
    Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
    Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
    Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
    Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
    Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous thymic lymphoma in severe combined immunodeficiency (SCID) mice engrafted with human peripheral blood lymphocytes.
    Monticello TM; Green DS; Yang H; Drain RL; Franco CT; Durham SK
    Vet Pathol; 1994 May; 31(3):393-5. PubMed ID: 8053140
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
    Katano I; Ito R; Eto T; Aiso S; Ito M
    Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
    Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
    Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice.
    Kishi Y; Tanaka Y; Shibata H; Nakamura S; Takeuchi K; Masuda S; Ikeda T; Muramatsu S; Hanazono Y
    Cell Transplant; 2008; 17(9):1095-102. PubMed ID: 19177845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engraftment of NOD/SCID/gammac(null) mice with multilineage neoplastic cells from patients with juvenile myelomonocytic leukaemia.
    Nakamura Y; Ito M; Yamamoto T; Yan XY; Yagasaki H; Kamachi Y; Kudo K; Kojima S
    Br J Haematol; 2005 Jul; 130(1):51-7. PubMed ID: 15982344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
    Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background data on NOD/Shi-scid IL-2Rγ
    Kasahara K; Fukunaga Y; Igura S; Andoh R; Saito T; Suzuki I; Kanemitsu H; Suzuki D; Goto K; Nakamura D; Mochizuki M; Yasuda M; Inoue R; Tamura K; Nagatani M
    J Toxicol Sci; 2017; 42(6):689-705. PubMed ID: 29142168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Existence of a threshold-like dose for gamma-ray induction of thymic lymphomas and no susceptibility to radiation-induced solid tumors in SCID mice.
    Ishii-Ohba H; Kobayashi S; Nishimura M; Shimada Y; Tsuji H; Sado T; Ogiu T
    Mutat Res; 2007 Jun; 619(1-2):124-33. PubMed ID: 17397880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.